Have a personal or library account? Click to login
Alcohol Septal Ablation Cover

Alcohol Septal Ablation

Journal of Biomedical and Clinical Research
Volume 8 (2015): Issue 2 (December 2015)
By: Desislava P. Petrova,  Sotir T. Marchev and  Boyko D. Kuzmanov  
Open Access
|Dec 2015

References

  1. 1. Maron BJ, McKenna WJ, Danielson GK, Kappenberger LJ, Kuhn HJ, Seidman CE, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42(9):1687-713.2).
    Search in Google Scholar
  2. 2. Maron BJ, Dearani JA, Ommen SR, Maron MS, Schaff HV, Gersh BJ, et al. The case for surgery in obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2004;44(10):2044-53.10.1016/j.jacc.2004.04.063
    Search in Google Scholar
  3. 3. Holmes DR Jr., Valeti US, Nishimura RA. Alcohol septal ablation for hypertrophic cardiomyopathy: indications and technique. Catheter Cardiovasc Interv. 2005;66(3):375-89.10.1002/ccd.20500
    Search in Google Scholar
  4. 4. Singh M, Edwards WD, Holmes DR Jr, Tajil AJ, Nishimura RA. Anatomy of the first septal perforating artery: a study with implications for ablation therapy for hypertrophic cardiomyopathy. Mayo Clin Proc. 2001;76(8):799-802.10.1016/S0025-6196(11)63224-2
    Search in Google Scholar
  5. 5. Faber L, Ziemssen P, Seggewiss H. Targeting percutaneous transluminal septal ablation for hypertrophic obstructive cardiomyopathy by intraprocedural echocardiographic monitoring. J Am Soc Echocardiogr. 2000;13(12):1074-9.10.1067/mje.2000.108250
    Search in Google Scholar
  6. 6. Monakier D, Woo A, Puri T, Schwartz L, Ross J, Jamorski M, et al. Usefulness of myocardial contrast echocardiographic quantification of risk area for predicting postprocedural complications in patients undergoing septal ethanol ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2004;94(12):1515-22.10.1016/j.amjcard.2004.08.030
    Search in Google Scholar
  7. 7. Faber L, Seggewiss H, Welge D, Fassbender D, Schmidt HK, Gleichmann U, et al. Echo-guided percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: 7 years of experience. Eur J Echocardiogr. 2004;5(5):347-55.10.1016/j.euje.2004.01.001
    Search in Google Scholar
  8. 8. Chang SM, Nagueh SF, Spencer WH 3rd, Lakkis NM. Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy. J Am Coll Cardiol. 2003;42(2):296-300.10.1016/S0735-1097(03)00623-5
    Search in Google Scholar
  9. 9. Kuhn H, Lawrenz T, Lieder F, Leuner C, Strunk-Mueller C, Obergassel L, et al. Survival after transcoronary ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy (TASH): a 10 year experience. Clin Res Cardiol. 2008;97(4):234-43.10.1007/s00392-007-0616-718071624
    Search in Google Scholar
  10. 10. Bhagwandeen R, Woo A, Ross J, Wigle ED, Rakowski H, Kwinter J, et al. Septal ethanol ablation for hypertrophic obstructive cardiomyopathy: early and intermediate results of a Canadian referral centre. Can J Cardiol. 2003;19(8):912-7.
    Search in Google Scholar
  11. 11. Veselka J, Duchonová R, Procházková S, Homolová I, Pálenícková J, Zemánek D, et al. The biphasic course of changes of left ventricular outflow gradient after alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Kardiol Pol. 2004;60(2):133-6.
    Search in Google Scholar
  12. 12. Sorajja P, Valeti U, Nishimura R, Ommen S, Rihal C, Gersh B. Outcome of Alkohol septal ablation of obstructive hypertrophic cardiomiopaty. Circulation. 2008;118:131-139.10.1161/CIRCULATIONAHA.107.73874018591440
    Search in Google Scholar
  13. 13. Angelini P. The “1st septal unit” in hypertrophic obstructive cardiomyopathy: a newly recognized anatomo-functional entity, identified during recent alcohol septal ablation experience. Tex Heart Inst J. 2007;34(3):336-46.
    Search in Google Scholar
  14. 14. Yoerger DM, Picard MH, Palacios IF, Vlahakes GJ, Lowry PA, Fifer MA. Time course of pressure gradient response after first alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Am J Cardiol. 2006;97(10):1511-4.10.1016/j.amjcard.2005.12.04016679095
    Search in Google Scholar
  15. 15. Henein MY, O'Sullivan CA, Ramzy IS, Sigwart U, Gibson DG. Electromechanical left ventricular behavior after nonsurgical septal reduction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 1999;34(4):1117-22.10.1016/S0735-1097(99)00332-0
    Search in Google Scholar
  16. 16. van Dockum WG, Kuijer JP, Götte MJ, Ten Cate FJ, Ten Berg JM, Beek AM, et al. Septal ablation in hypertrophic obstructive cardiomyopathy improves systolic myocardial function in the lateral (free) wall: a follow-up study using CMR tissue tagging and 3D strain analysis. Eur Heart J. 2006;27(23):2833-9.10.1093/eurheartj/ehl35817098761
    Search in Google Scholar
  17. 17. van Dockum WG, Beek AM, ten Cate FJ, ten Berg JM, Bondarenko O, Götte MJ, et al. Early onset and progression of left ventricular remodeling after alcohol septal ablation in hypertrophic obstructive cardiomyopathy. Circulation. 2005;111(19): 2503-8.10.1161/01.CIR.0000165084.28065.0115867172
    Search in Google Scholar
  18. 18. Mazur W, Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Roberts R, et al. Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 2001;103(11):1492-6.10.1161/01.CIR.103.11.149211257074
    Search in Google Scholar
  19. 19. Veselka J, Prochazkova S, Bolomova-Homolova I, Duchonova R, Tesar D. Effects of alcohol septal ablation for hypertrophic obstructive cardiomyopathy on Doppler Tei index: a midterm follow-up. Echocardiography. 2005;22(2):105-9.10.1111/j.0742-2822.2005.03148.x15693775
    Search in Google Scholar
  20. 20. Nagueh SF, Lakkis NM, Middleton KJ, Killip D, Zoghbi WA, Quiñones MA, et al. Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation. 1999;99(3):344-7.10.1161/01.CIR.99.3.344
    Search in Google Scholar
  21. 21. El-Jack SS, Nasif M, Blake JW, Dixon SR, Grines CL, O'Neill WW. Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation. J Interv Cardiol. 2007;20(1):73-6.10.1111/j.1540-8183.2007.00220.x17300408
    Search in Google Scholar
  22. 22. Faber L, Welge D, Fassbender D, Schmidt HK, Horstkotte D, Seggewiss H. Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure related AV conduction disturbances. Int J Cardiol. 2007;119(2):163-7.10.1016/j.ijcard.2006.07.17917067708
    Search in Google Scholar
  23. 23. Faber L, Seggewiss H, Welge D, Fassbender D, Ziemssen P, Schmidt HK, et al. Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy. Z Kardiol. 2003;92(1):39-47.10.1007/s00392-003-0878-712545300
    Search in Google Scholar
  24. 24. Knight CJ. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Heart. 2006;92(9):1339-44.10.1136/hrt.2005.063677186120416908721
    Search in Google Scholar
  25. 25. Gietzen FH, Leuner CJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C, et al. Acute and longterm results after transcoronary ablation of septal hypertrophy TASH). Catheter interventional treatment for hypertrophic obstructive cardiomyopathy. Eur Heart J. 1999;20(18):1342-54.10.1053/euhj.1999.152010462469
    Search in Google Scholar
  26. 26. Kuhn H, Seggewiss H, Gietzen FH, Boekstegers P, Neuhaus L, Seipel L. Catheter-based therapy for hypertrophic obstructive cardiomyopathy. First in-hospital outcome analysis of the German TASH Registry. Z Kardiol. 2004;93(1):23-31.10.1007/s00392-004-1028-614740238
    Search in Google Scholar
  27. 27. Hori Y, Ueda M, Nakayama T, Saegusa N, Uehara M, Lee K, et al. Occurrence of de novo sustained monomorphic ventricular tachycardia induced after percutaneous transluminal alcohol septal myocardial ablation for hypertrophic obstructive cardiomyopathy. Int J Cardiol. 2007;119(3):403-7.10.1016/j.ijcard.2006.07.18217069908
    Search in Google Scholar
  28. 28. Simon RD, Crawford FA 3rd, Spencer WH 3rd, Gold MR. Sustained ventricular tachycardia following alcohol septal ablation for hypertrophic obstructive cardiomyopathy. Pacing Clin Electrophysiol. 2005;28(12):1354-6.10.1111/j.1540-8159.2005.00278.x16403169
    Search in Google Scholar
  29. 29. Boltwood CM Jr., Chien W, Ports T. Ventricular tachycardia complicating alcohol septal ablation. N Engl J Med. 2004;351(18):1914-5.10.1056/NEJM20041028351182415509832
    Search in Google Scholar
  30. 30. McGregor JB, Rahman A, Rosanio S, Ware D, Birnbaum Y, Saeed M. Monomorphic ventricular tachycardia: a late complication of percutaneous alcohol septal ablation for hypertrophic cardiomyopathy. Am J Med Sci. 2004;328(3):185-8.10.1097/00000441-200409000-0001115367880
    Search in Google Scholar
  31. 31. Alam M, Dokainish H, Lakkis N. Alcohol septal ablation for hypertrophic_obstructive cardiomyopathy: a systematic review of published studies. J Interv Cardiol. 2006;19(4):319-27.10.1111/j.1540-8183.2006.00153.x16881978
    Search in Google Scholar
  32. 32. van Dockum WG, ten Cate FJ, ten Berg JM, Beek AM, Twisk JW, Vos J, et al. Myocardial infarction after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: evaluation by contrast-enhanced magnetic resonance imaging. J Am Coll Cardiol. 2004;43(1):27-34.10.1016/j.jacc.2003.08.03114715178
    Search in Google Scholar
  33. 33. Zeng Z, Wang F, Dou X, Zhang S, Pu J. Comparison of percutaneous transluminal septal myocardial ablation versus septal myectomy for the treatment of patients with hypertrophic obstructive cardiomyopathy--a meta analysis. Int J Cardiol. 2006;112(1):80- 4.10.1016/j.ijcard.2005.10.00916507323
    Search in Google Scholar
  34. 34. Fifer MA. Controversies in cardiovascular medicine. Most fully informed patients choose septal ablation over septal myectomy. Circulation. 2007;116(2):207-16.10.1161/CIRCULATIONAHA.107.68813517620520
    Search in Google Scholar
  35. 35. Nagueh SF, Buergler JM, Quinones MA, Spencer WH 3rd, Lawrie GM. Outcome of surgical myectomy after unsuccessful alcohol septal ablation for the treatment of patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2007;50(8):795-8.10.1016/j.jacc.2007.04.065
    Search in Google Scholar
  36. 36. Ralph-Edwards A, Woo A, McCrindle BW, Shapero JL, Schwartz L, Rakowski H, et al. Hypertrophic obstructive cardiomyopathy: comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score. J Thorac Cardiovasc Surg. 2005;129(2):351-8.10.1016/j.jtcvs.2004.08.047
    Search in Google Scholar
  37. 37. Nagueh SF, Ommen SR, Lakkis NM, Killip D, Zoghbi WA, Schaff HV, et al. Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol. 2001;38(6):1701-6.10.1016/S0735-1097(01)01614-X
    Search in Google Scholar
  38. 38. Firoozi S, Elliott PM, Sharma S, Murday A, Brecker SJ, Hamid MS, et al. Septal myotomymyectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes. Eur Heart J. 2002;23(20):1617-24.10.1053/euhj.2002.328512323162
    Search in Google Scholar
DOI: https://doi.org/10.1515/jbcr-2015-0159 | Journal eISSN: 1313-9053
Journal RSS Feed
Language: English
Page range: 104 - 111
Submitted on: Apr 4, 2015
|
Accepted on: Dec 1, 2015
|
Published on: Dec 22, 2015
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Publication frequency: 2 issues per year
Keywords:
hypertrophic cardiomyopathy,
left ventricular outflow obstruction,
alcohol septal ablation
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other,
Ophthalmology,
Public health,
Pharmacy,
Clinical pharmacy

© 2015 Desislava P. Petrova, Sotir T. Marchev, Boyko D. Kuzmanov, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 8 (2015): Issue 2 (December 2015)Next article